AstraZeneca's Investment Eats Into Profit

AstraZeneca said core profit fell in the first quarter even as revenue rose, as it plowed heavy investment into the development of a string of new drugs it is betting on for growth.

from WSJ.com: US Business http://ift.tt/1rmSMrY
via IFTTT